【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market share analysis, 2018
3.4. Porters five forces analysis
3.5. Clinical trials
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in prevalence of cancer
3.6.1.2. Surge in cancer research
3.6.1.3. Rise in strategic acquisitions & collaborations
3.6.2. Restraints
3.6.2.1. High cost of drug development and threat of failure
3.6.2.2. Adverse effects associated with cancer drug therapy
3.6.3. Opportunities
3.6.3.1. High potential associated with personalized medicines
3.6.3.2. Increase in purchasing power of emerging economies
CHAPTER 4: CANCER THERAPEUTICS MARKET, APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Blood cancer
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Lung cancer
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Breast cancer
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Colorectal cancer
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Prostate cancer
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Cervical cancer
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Head & neck cancer
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. Glioblastoma
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
4.10. Malignant meningioma
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country
4.11. Mesothelioma
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast, by region
4.11.3. Market analysis, by country
4.12. Melanoma
4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country
4.13. Others
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast, by region
4.13.3. Market analysis, by country
CHAPTER 5: CANCER THERAPEUTICS MARKET, BY TOP SELLING DRUGS
5.1. Overview
5.1.1. Market size and forecast
5.2. Revlimid
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region
5.3. Avastin
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region
5.4. Herceptin
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region
5.5. Rituxan
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region
5.6. Opdivo
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region
5.7. Gleevec
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region
5.8. Velcade
5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by region
5.9. Imbruvica
5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by region
5.10. Ibrance
5.10.1. Market size and forecast, by region
5.10.2. Market analysis, by region
5.11. Zytiga
5.11.1. Market size and forecast, by region
5.11.2. Market analysis, by region
5.12. Alimta
5.12.1. Market size and forecast, by region
5.12.2. Market analysis, by region
5.13. Xtandi
5.13.1. Market size and forecast, by region
5.13.2. Market analysis, by region
5.14. Tarceva
5.14.1. Market size and forecast, by region
5.14.2. Market analysis, by region
5.15. Perjeta
5.15.1. Market size and forecast, by region
5.15.2. Market analysis, by region
5.16. Temodar
5.16.1. Market size and forecast, by region
5.16.2. Market analysis, by region
5.17. Other drugs
5.17.1. Market size and forecast, by region
5.17.2. Market analysis, by region
CHAPTER 6: CANCER THERAPEUTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by application
6.2.3. North America market size and forecast, by application
6.2.4. North America market size and forecast, by top selling drugs
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe cancer therapeutics market, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by application
6.3.2.5. Spain
6.3.2.5.1. Spain market size and forecast, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe market size and forecast, by application
6.3.3. Europe market size and forecast, by application
6.3.4. Europe market size and forecast, by top selling drugs
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by application
6.4.2.2. China
6.4.2.2.1. China market size and forecast, by application
6.4.2.3. India
6.4.2.3.1. India market size and forecast, by application
6.4.2.4. Taiwan
6.4.2.4.1. Taiwan market size and forecast, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea market size and forecast, by application
6.4.2.6. Australia
6.4.2.6.1. Australia market size and forecast, by application
6.4.2.7. Rest of Asia-Pacific
6.4.2.7.1. Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by application
6.4.4. Asia-Pacific market size and forecast, by top selling drugs
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.2.1. Latin America
6.5.2.1.1. Latin America market size and forecast, by application
6.5.2.2. Middle East
6.5.2.2.1. Middle East market size and forecast, by application
6.5.2.3. Africa
6.5.2.3.1. Africa market size and forecast, by application
6.5.3. LAMEA market size and forecast, by application
6.5.4. LAMEA market size and forecast, by top selling drugs
CHAPTER 7: COMPANY PROFILES
7.1. AbbVie Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Astellas Pharma Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Bristol Myers Squibb Company
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Celgene Corporation
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Eli Lilly and Company
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. F. Hoffmann-La Roche Ltd.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. EleInformatiBusiness performance
7.6.6. Key strategic moves and developments
7.7. Johnson & Johnson
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Merck & Co., Inc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Novartis AG
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Pfizer Inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
【レポート販売概要】
■ タイトル：がん治療法の世界市場：用途別、人気商品別■ 英文：Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年7月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV072
■ 調査対象地域：グローバル
- Machine-to-Machine (M2M) and RFIDMachine-to-Machine (M2M) communications and Radio Frequency ID (RFID) together represent a means of direct communication between connection hardware and the object that needs monitoring: the information about its status of performance is directly sent to a computer system without the need for human intervention. This makes automation of processes or consumer action possible. The technology that ut …
- 世界のカミソリ及びカミソリ用刃市場（～2019）：主要10か国This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for razors and razor blades in the world and in the top 10 global countries. Along with a global razor and razor blade market report the package includes country reports from the following countries: China, Czech Republic, France, Germany, India, Japan, Mexico, Poland, Uni …
- おむつかぶれ用のクリームの世界市場About Baby Diaper Rash Cream A diaper rash develops when skin is exposed to prolonged wetness, bacterial infection, urine and feces, constant friction, infrequently changed diapers, using plastic pants to cover diapers, and diarrhea. It can lead to frequent crying, changes in sleeping patterns and eating habits, restlessness and agitated behavior, and reduced urination and/or defecation from the b …
- 民間航空機用バッテリーの世界市場：ニッケルカドミウムバッテリー、リチウムバッテリーThe global commercial aircraft batteries and accessories market is estimated to grow at a CAGR of 7.3% from 2014 to 2019. Although the developing markets (such as the China, India, and Japan) hold larger shares in the global commercial aircraft batteries and accessories market, the Middle East region is expected to grow at the fastest CAGR of 8.4% during the forecast period, 2014 to 2019. The grow …
- テラヘルツ及び赤外分光の世界市場：波長（近赤外線/中赤外線/遠赤外線）、技術（ベンチトップ/ポータブル&携帯型）、用途別分析The demand for terahertz and infrared spectroscopy systems has been on the rise due to growth in the semiconductors industry, rising use of THz spectroscopy in homeland security, and burgeoning requirements of the life sciences, pharmaceutical, and chemical industries. Various regulatory authorities across industries have enforced stringent safety regulations in order to ensure that the products l …
- Abu Dhabi National Oil Company：石油・ガスバリューチェーン分析レポート2013Abu Dhabi National Oil Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Abu Dhabi National Oil Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Abu Dhabi National Oil Company”. The report provides key information relating to oil and gas assets of the company along with its operations across th …
- オフグリッド・エネルギー貯蔵システムの世界市場2016-2020About Off-Grid Power Generation Systems Off-grid power generation systems are generally used when there are capital limitations or the physical landscape makes it tough to have a grid connection. Off-grid energy storage systems are used in localities that are far away from populated areas or cities and not connected to any electricity grid. In these regions, despite the presence of independent pow …
- 医療料金アウトソーシングの世界市場2015-2019About Global Medical Billing Outsourcing Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility rate; in emerging countries, it is the lack of infrastructure, increase in chronic diseases, and inequ …
- 世界の癌検査（医療機器）市場：サプライヤーシェア及び市場予測Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “2014 Opportunities in the Global Cancer Diagnostics Market” is a new seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the U.S., five major European count …
- Concentrated Photovoltaic (CPV), 2012 – Global Market Size, Average Installation Price, Market Share, Regulations and Key Country Analysis to 2020Concentrated Photovoltaic (CPV), 2012 - Global Market Size, Average Installation Price, Market Share, Regulations and Key Country Analysis to 2020 Summary “Concentrated Photovoltaic (CPV), 2012 - Global Market Size, Average Installation Price, Market Share, Regulations and Key Country Analysis to 2020” is an alternative energy offering from GlobalData that offer comprehensive information and under …
- SSL証明書の世界市場2016-2020Technavios market research analyst predicts the global SSL certification market to grow at an impressive CAGR of more than 22% by 2020. The consumers growing preference for online banking and e-commerce is a significant factor that is expected to impel market growth during the forecast period. The augmented need for privacy and security is the key driver for the growth of this market. Recently, it …
- 世界の飼料用酵素市場：種類別（フィターゼ、カルボヒドラーゼ、およびプロテアーゼ）、家畜別（家禽、豚、反すう動物、水生動物）、由来別（微生物、植物、動物）、フォーム別（乾燥および液体）、地域別“Provision of cost-efficiency in the usage of feed and increasing demand for animal-based products, such as meat products, dairy products, and eggs, are projected to drive the growth of the global feed enzymes market.” The global feed enzymes market size is projected to grow from USD 1.2 billion in 2019 to USD 2.0 billion by 2025, at a CAGR of 9.1% during the forecast period. Provision of maintain …
- ドイツの移動補助・運搬機器市場見通し（～2021）Germany Mobility Aids and Transportation Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Germany Mobility Aids and Transportation Equipment Market Outlook to 2021", provides key market data on the Germany Mobility Aids and Transportation Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market …
- 顧客経験管理（CEM）の世界市場予測（～2020）Customer experience management is a collection of processes, which use a variety of technologies to gather customer feedback, understand their expectations, and improve the overall customer experience to reach new markets through different touchpoints. The aim of CEM is to move the customer from satisfied to loyal, and to make them promoters of the brand. Telecommunication service providers; banki …
- 浮体式生産システムのグローバル市場動向（～2018）This report estimates the floating production systems market in terms of volume and value. The volume market is estimated in terms of number of orders booked per year and value in terms of contract value. This has been broken down into component regions and is further split into countries. Floating production systems are required for oil and gas development. The ever-increasing offshore exploratio …
